Trials / Sponsors / Everfront Biotech Co., Ltd.
Everfront Biotech Co., Ltd.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma Recurrent Glioblastoma, IDH-Wildtype | Phase 2 / Phase 3 | 2026-11-01 |
| Not Yet Recruiting | A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2025-09-01 |
| Active Not Recruiting | To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers Amyotrophic Lateral Sclerosis | Phase 1 | 2021-02-01 |
| Completed | A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Recurrent GBM | Phase 1 / Phase 2 | 2017-11-01 |